Total Credits: 1.0 including 1.0 AOA Category 1-A Credit(s), 1.0 AMA PRA Category 1 Credit(s)™
Monkeypox 2022
Robert Orenstein, DO
Dr. Orenstein will discuss the off-label use of Brincidofovir and Tecovirimat for Monkeypox.
Accreditation
The Arizona Osteopathic Medical Association (AOMA) is accredited by the American Osteopathic Association (AOA) to provide osteopathic continuing medical education for physicians.
The AOMA designates this activity for a maximum of 1.0 hour of AOA Category 1-A credits and will report CME and specialty credits commensurate with the extent of the physician's participation in this activity.
The Arizona Osteopathic Medical Association (AOMA) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
The AOMA designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
AOMA Grievance Policy: The Arizona Osteopathic Medical Association strives to provide continuing medical education programs to fulfill the needs of the attendees and to meet the AOA Accreditation Requirements and ACCME Accreditation Requirements. Comments, questions, or complaints should be submitted in writing to Teresa Roland, Director of Education, by mail to AOMA, 3039 W Peoria Ave, Suite C102-158, Phoenix, AZ 85029, or email teresa@azosteo.org.
|
Monkeypox 2022
(5.9 MB)
Robert Orenstein, DO |
Available after Purchase | ||
Dr. Robert Orenstein is a professor of medicine and a senior fellow in the Academy of Educational Excellence at The Mayo Clinic College of Medicine and Science. He has been the Chair of the Division of Infectious Diseases at Mayo Clinic Arizona since 2012. He is board certified in infectious diseases, internal medicine and certified in Travel medicine and a fellow of the Infectious Diseases Society of America. He served as the Editor-in-Chief for the American Osteopathic Association from 2013-2020. Dr. Orenstein is an alumnus of the Des Moines University College of Osteopathic Medicine. He has received numerous awards for his educational efforts, including receiving the 2019 American Academy of Osteopathy’s, Academy Award, its highest service award for a non-member and the 2021 recipient of Mayo’s Above and Beyond Clinician Award.
Dr Orenstein practices infectious diseases at the Mayo Clinic Arizona, Phoenix campus where he sees complex inpatient and outpatient consultations in general and transplant infectious diseases. He is the founder of the Mayo Clinic Microbial Restoration Therapeutics Program and the C. difficile treatment program. He has played a leadership role in organizing Mayo’s response to both the COVID-19 and Monkeypox public health emergencies. He is currently leading a CDC/Arizona Department of Health Services sponsored Emerging Therapeutics Consortium focused on health equity and improving education on emerging infections across the state.